FDA — authorised 29 December 2005
- Marketing authorisation holder: CUMBERLAND PHARMS
- Status: approved
🇺🇸 Vaprisol In 5% Dextrose In Plastic Container in United States
FDA authorised Vaprisol In 5% Dextrose In Plastic Container on 29 December 2005
Marketing authorisations
FDA — authorised 29 December 2005
- Application: NDA021697
- Marketing authorisation holder: CUMBERLAND
- Local brand name: VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
Vaprisol In 5% Dextrose In Plastic Container in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Vaprisol In 5% Dextrose In Plastic Container approved in United States?
Yes. FDA authorised it on 29 December 2005; FDA authorised it on 29 December 2005.
Who is the marketing authorisation holder for Vaprisol In 5% Dextrose In Plastic Container in United States?
CUMBERLAND PHARMS holds the US marketing authorisation.